2-5 October 2021
34th European College Neuropsychopharmacology (ECNP) congress 2021
Location: virtual meeting
e-Poster Title: “PORTICO – Phase IIb trial evaluating vafidemstat, an epigenetic therapeutic approach, for the treatment of Borderline Personality Disorder”
Presenter: Dr. Michael Ropacki, Oryzon’s CMO for CNS